---
aliases: [United Kingdom, Britain, Great Britain]
---
#actor #country #europe #finance #pharma

**UK** — World's 6th largest economy. Finance hub, Arm Holdings, pharma strength. Post-Brexit recalibration.

---

## Why UK matters

| Metric | Value |
|--------|-------|
| GDP | ~$3.3T (#6 globally) |
| Population | 67M |
| Key sectors | Finance, pharma, defense, tech IP |
| Government | Labour (Keir Starmer) |
| Currency | GBP |

---

## Key sectors

### Finance

| Institution | Role |
|-------------|------|
| London | Global financial center (#2) |
| HSBC | Largest UK bank (Asia focus) |
| Barclays | Investment banking |
| Lloyd's | Insurance market |
| LSE Group | Exchanges, data |

**Post-Brexit:** Lost some EU passporting, but remains major center.

### Semiconductors / Tech IP

| Company | Focus |
|---------|-------|
| [[Arm Holdings]] | CPU architecture (90%+ mobile) |
| Imagination Tech | GPU IP |
| Graphcore | AI accelerators |

**Arm** is UK's tech crown jewel — ~$150B market cap.

### Pharma / Life Sciences

| Company | Focus |
|---------|-------|
| [[AstraZeneca]] | Oncology, vaccines |
| GSK | Vaccines, specialty pharma |
| Haleon | Consumer health (GSK spinoff) |

### Defense

| Company | Focus |
|---------|-------|
| BAE Systems | Full spectrum, US presence |
| Rolls-Royce | Jet engines, nuclear |
| QinetiQ | R&D, cyber |

### Energy

| Company | Focus |
|---------|-------|
| [[BP]] | Oil & gas major |
| Shell | HQ moved to UK |
| National Grid | Utilities |

---

## Post-Brexit dynamics

| Factor | Status |
|--------|--------|
| Trade friction | Increased with EU |
| Financial passporting | Partially lost |
| Regulatory autonomy | Gained |
| Immigration | Points-based system |
| Tech/AI regulation | Lighter than EU |

**Opportunity:** Positioning as AI-friendly jurisdiction vs EU regulation.

---

## Investment themes

| Theme | Expression |
|-------|------------|
| Tech IP | [[Arm Holdings]] |
| Pharma | [[AstraZeneca]], GSK |
| Defense | BAE Systems (US exposure) |
| Energy transition | BP, Shell repositioning |
| Finance | HSBC (Asia), LSE Group (data) |

---

## Key companies

| Company | Ticker | Sector |
|---------|--------|--------|
| [[Arm Holdings]] | ARM | Tech IP |
| [[AstraZeneca]] | AZN | Pharma |
| Shell | SHEL | Energy |
| [[BP]] | BP | Energy |
| HSBC | HSBA.L | Banking |
| BAE Systems | BA.L | Defense |
| Rolls-Royce | RR.L | Aerospace |
| GSK | GSK | Pharma |
| Unilever | ULVR.L | Consumer |
| Rio Tinto | RIO | Mining |

---

## Structural challenges

| Challenge | Impact |
|-----------|--------|
| Brexit trade friction | Export headwinds |
| Productivity | Chronic underperformance |
| Housing | Affordability crisis |
| NHS | Healthcare capacity strain |
| Scotland | Independence debates |

---

## Related

- [[Europe]] — regional hub
- [[Arm Holdings]] — tech crown jewel
- [[AstraZeneca]] — pharma champion
- [[BP]] — energy major
- [[Defense]] — BAE Systems exposure

---

*Created 2026-01-10*
